FDA's CTAP Dashboard Brings Transparency to COVID-19 Therapies

The U.S. FDA announced the creation a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). This program, updated on November 17, 2020, uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.

As of October 31, 2020, the CTAP snapshot can be found at this FDA link.